Study of Everolimus (RAD001) in Combination With Lenalidomide

NCT01218555 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Solid Organ Malignancies
Adenoidcystic Carcinoma
Neuroendocrine Tumors

Interventions

DRUG: Lenalidomide
DRUG: Everolimus

Sponsor

Emory University

Collaborators

[object Object]
[object Object]